JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

El metilfenidato como un nuevo complemento en pacientes que toman opioides: información sobre la neuroadaptación dopaminérgica y el delirio hipoactivo

  • 0Student Scientific Organisation of Department and Clinic of Adult Psychiatry, Faculty of Medical Sciences, Medical University of Silesia, Ziolowa 45, 40-635 Katowice, Poland.
Brain Sciences +

|

28 de agosto de 2025

|

28 de agosto de 2025

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

El metilfenidato (MPH) puede ayudar a tratar el trastorno por uso de opiáceos (OUD) mediante la restauración de los niveles de dopamina. Se necesita más investigación para confirmar su eficacia y seguridad en pacientes con OUD.

Área De La Ciencia

  • La neurociencia
  • Farmacología
  • Medicina para la adicción

Sus Antecedentes

  • La epidemia de opioides requiere nuevos tratamientos para el trastorno por consumo de opioides.
  • La comprensión de las superposiciones neurobiológicas entre el OUD y el metilfenidato (MPH) es crucial.

Objetivo Del Estudio

  • Explorar las conexiones teóricas entre la neurobiología de OUD y la farmacodinámica de MPH.
  • Examinar los objetivos moleculares compartidos, la seguridad y el potencial terapéutico de MPH en OUD.

Principales Métodos

  • Revisión de los mecanismos neurobiológicos en el desarrollo de OUD.
  • Análisis de las acciones dopaminérgicas de la MPH (inhibición de la recaptación de dopamina, modulación de VMAT-2).
  • Consideración de los efectos de la MPH en la regulación cognitiva y afectiva.

Principales Resultados

  • La dependencia de opiáceos implica refuerzo negativo a través de la vía mesolímbica de la hipodopaminergia.
  • El MPH mejora la señalización dopaminérgica, contrarrestando potencialmente la hipodopaminergia inducida por los opioides.
  • La MPH ha demostrado beneficios en condiciones similares como el delirio hipoactivo.

Conclusiones

  • Existen mecanismos neurobiológicos convergentes entre la acción de la MPH y la fisiopatología de la OUD, particularmente en el sistema dopaminérgico.
  • Los ensayos clínicos son esenciales para validar la eficacia y la seguridad de MPH e identificar subgrupos de pacientes adecuados para el tratamiento de OUD.

Palabras clave:

Videos de Conceptos Relacionados

Antidepressant Drugs: MAOIs and Other Agents 01:23

340

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Opioid Analgesics: Synthetic and Semisynthetic Opioids 01:15

421

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids 01:24

324

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...

Drug Therapy 01:28

96

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Parkinson's Disease: Treatment 01:24

376

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Adrenergic Agonists: Indirect-Acting Agents 01:25

1.8K

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...